02/21/2025
4:25 PM | HCW Biologics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/21/2025
4:29 PM | HCW Biologics (Filer)
| Form DEF 14A | |
02/11/2025
3:54 PM | HCW Biologics (Filer)
| Form PRE 14A | |
02/07/2025
3:45 PM | HCW Biologics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/03/2025
6:30 AM | HCW Biologics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/23/2024
7:30 AM | HCW Biologics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/05/2024
3:37 PM | HCW Biologics (Filer)
| Form D
Notice of Exempt Offering of Securities | |
11/22/2024
3:53 PM | HCW Biologics (Subject)
Wong Hing C (Filed by)
| Form SC 13D/A | |
11/22/2024
3:45 PM | HCW Biologics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/20/2024
11:54 AM | HCW Biologics (Filer)
| Form 424B2
Transaction specifc information for a delayed shelf offering | |
11/18/2024
6:00 AM | HCW Biologics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Get the Latest News and Ratings for HCWB and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for HCW Biologics and its competitors with MarketBeat's FREE daily newsletter. |
09/20/2024
4:25 PM | HCW Biologics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/23/2024
3:35 PM | HCW Biologics (Filer)
| Form 8-K/A | |
08/14/2024
3:45 PM | HCW Biologics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/14/2024
3:40 PM | HCW Biologics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/12/2024
3:35 PM | HCW Biologics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/18/2024
6:00 AM | HCW Biologics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/20/2024
3:30 PM | HCW Biologics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/17/2024
3:56 PM | HCW Biologics (Issuer)
Winer Gary M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2024
3:57 PM | Greene Rick S. (Reporting)
HCW Biologics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2024
3:33 PM | HCW Biologics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/20/2024
3:36 PM | HCW Biologics (Filer)
| Form ARS/A | |
05/15/2024
4:21 PM | HCW Biologics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/15/2024
3:45 PM | HCW Biologics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/15/2024
3:35 PM | HCW Biologics (Filer)
| Form 10-K/A | |
05/01/2024
4:21 PM | HCW Biologics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/26/2024
6:40 AM | HCW Biologics (Filer)
| Form DEFA14A | |
04/26/2024
6:30 AM | HCW Biologics (Filer)
| Form DEF 14A | |
04/26/2024
6:30 AM | HCW Biologics (Filer)
| Form ARS | |
04/01/2024
3:31 PM | HCW Biologics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
04/01/2024
3:15 PM | HCW Biologics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/27/2024
3:27 PM | HCW Biologics (Filer)
| Form D
Notice of Exempt Offering of Securities | |
02/22/2024
1:19 PM | Byam Rebecca (Reporting)
HCW Biologics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/22/2024
1:20 PM | Flowers Lee (Reporting)
HCW Biologics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/22/2024
1:21 PM | GARRETT SCOTT T (Reporting)
HCW Biologics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/22/2024
1:22 PM | Giles Lisa M. (Reporting)
HCW Biologics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/22/2024
1:23 PM | Greene Rick S. (Reporting)
HCW Biologics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/22/2024
1:24 PM | HCW Biologics (Issuer)
Wong Hing C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/22/2024
7:39 AM | HCW Biologics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
